FIELD: medicine, gynecology.
SUBSTANCE: it is necessary to monitor the content of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), progesterone (P) in blood serum on the 7th, 14th, 21st d of menstrual cycle due to immunoenzymatic technique. At FSH values ranged 4.98-5.78 IU/l on the 7th d of menstrual cycle, 9.88-11.52 IU/l on the 14th d of menstrual cycle, 6.91-7.85 IU/l on the 21st d of menstrual cycle, LH ranged 5.11-5.75 mIU/l on the 7th d of menstrual cycle, 11.7-12.23 mIU/l on the 14th d of menstrual cycle, 5.66-7.18 mIU/l on the 21st d of menstrual cycle, E2 ranged 41.28-44.93 pg/ml on the 7th d of menstrual cycle, 134.78-143.92 pg/ml on the 14th d of menstrual cycle, 98.91-109.29 pg/ml on the 21st d of menstrual cycle, Pranged 1.02-1.53 nM/l on the 7th d of menstrual cycle, 1.31-1.79 nM/l on the 14th d of menstrual cycle, 6.80-7.16 nM/l on the 21st d of menstrual cycle one should diagnose the ectopia of uterine cervix in females of reproductive age.
EFFECT: higher accuracy of diagnostics.
1 ex, 2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 | 
 | RU2578459C1 | 
| METHOD FOR PREDICTING HOLLOW FOLLICLES SYNDROME | 2005 | 
 | RU2302639C1 | 
| METHOD FOR TREATING DYSFUNCTIONAL UTERINE HEMORRHAGES AT GLANDULAR-CYSTIC HYPERPLASIA AND ENDOMETRIAL POLYPS | 2006 | 
 | RU2310459C1 | 
| METHOD OF DIAGNOSTICS OF MENSTRUAL DYSFUNCTION AGAINST BACKGROUND OF POLYCYSTIC OVARIAN SYNDROME BY IMMATURE GIRLS | 2013 | 
 | RU2535096C1 | 
| METHOD OF TREATING POLYCYSTIC OVARY SYNDROME WITH NON-HORMONAL PREPARATIONS | 2020 | 
 | RU2732688C1 | 
| METHOD FOR PREDICTION OF MENSTRUAL RECOVERY IN ADOLESCENT GIRLS WITH NORMOGONADOTROPIC OLIGOMENORRHEA | 2020 | 
 | RU2740848C1 | 
| INSTANT DIAGNOSTIC TECHNIQUE FOR FEMALE ENDOCRINE INFERTILITY | 2014 | 
 | RU2574669C2 | 
| METHOD FOR AROMATASE ACTIVITY TEST | 2012 | 
 | RU2481587C1 | 
| METHOD FOR IN VITRO FERTILIZATION (IVF) IN NATURAL CYCLE IN ABSENCE OF HYPERPROLACTINEMIA | 2024 | 
 | RU2834540C1 | 
| METHOD FOR TREATING STERILITY CAUSED BY HYPERANDROGENY AND HYPERPROLACTINEMIA | 2003 | 
 | RU2237491C1 | 
Authors
Dates
2007-09-20—Published
2006-04-12—Filed